According to Cologuard, made by Wisconsin-based Exact Sciences, there are three primary reasons why you may receive a testing ...

Geneoscopy announced new data in Practical Laboratory Medicine validating the reliability of the scrape-free collection ...

Colorectal cancer is the second leading cause of cancer-related deaths for males and females. Screening for colorectal cancer ...

Among nearly 25 million privately insured adults, significant shifts in colorectal cancer (CRC) screening practices were identified after the onset of COVID-19. 1 Between 2017 and 2024, colonoscopy ...

Insurers should stop mailing colorectal cancer screening kits without the involvement of the patients’ physicians. Doctors ...

Consumers have testing options beyond the once-a-decade colonoscopy. But some doctors question Cologuard's testing program.

Colon cancer is the leading cause of cancer death in men under 50 and the second leading cause in women of the same age, according to the American Cancer Society.

Colon cancer is the most commonly diagnosed cancer and third leading cause of cancer deaths. It is also one of the most preventable types of cancer when it is detected early. Colon cancer screening ...

NEW YORK, Oct. 28 (UPI) --New blood tests screen for colorectal cancer in a much less invasive way than colonoscopy, but deaths will increase if many people choose this alternative, a new study ...

Screening for the second leading cause of cancer deaths just got a bit easier. The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal cancer (CRC).

Guardant Health stock has had several attempts at breaking out of a cup base. The company has a blood test to detect colon ...

The Kentucky Colon Cancer Screening Program has asked the General Assembly for an increase in state funding from $500,000 per ...